用抗PD-1和alendronate涂覆的工程瘤性病毒用于改善内T细胞低功能的
Yufu Zhu1,2, Xuefeng Zhang3, Jiaqi Jin3,4
1Institute of Nervous System Diseases, Xuzhou Medical University, No.84 Huaihai West Road, Xuzhou, 221002, China. fugle99@126.com.
Experimental hematology & oncology
|February 15, 2025
概括
这项研究开发了一种新型瘤性病毒疗法 (PD-1/Al@OV),可增强T细胞功能,降低免疫抑制,为质母细胞瘤提供了有前途的新疗法.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 病毒学 病毒学
背景情况:
- 质母细胞瘤是一种致命的脑瘤,对当前的治疗方法有抗性.
- 瘤病毒看起来有前途,但面临着诸如短期持久性和免疫抑制等挑战.
- T细胞功能障碍限制了现有的免疫疗法的有效性.
研究的目的:
- 开发一种新的治疗策略,用于质母细胞瘤使用改性瘤病毒.
- 克服当前瘤性病毒疗法的局限性.
- 增强抗瘤免疫反应,改善免疫治疗结果.
主要方法:
- 开发出具有抗PD-1抗体和alendronate的"穿着"型病毒 (PD-1/Al@OV).
- 研究了瘤微环境中的组件的in-situ释放和功能.
- 评估了对T细胞激活,巨细胞枯竭和病毒疗效的影响.
主要成果:
- 在瘤微环境中分解PD-1/Al@OV,释放活性成分.
- 抗PD-1阻塞通过抑制PD-1/PD-L1通路激活T细胞.
- 阿伦德罗纳酸降低了与瘤相关的巨细胞,增加了瘤性病毒度和瘤内T细胞透.
结论:
- 这种新的策略有效地逆转了质母细胞瘤的免疫抑制微环境.
- 获得了显著的抗瘤效果,证明了这种免疫组合疗法的潜力.
- 提供了改进使用瘤病毒治疗质母细胞瘤的新前景.
更多相关视频
08:55Transarterial Administration of Oncolytic Viruses for Locoregional Therapy of Orthotopic HCC in Rats
Published on: April 15, 2016
9.4K
10:18Author Spotlight: Magnetic Fluorescent Bead-Based Dual-Reporter Flow Analysis of PDL1-Vaxx Peptide Vaccine-Induced Antibody Blockade of the PD-1/PD-L1 Interaction
Published on: July 7, 2023
1.1K
相关概念视频
01:27Tumor Immunotherapy
463
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
463
02:49Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
01:30Cancer Vaccines
327
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
327